Applied Clinical Trials-08-01-2016

August 01, 2016

The need to revise the design, performance and interpretation of clinical research to reflect changing methods and standards is drawing increased attention.

August 01, 2016

The uncertainty surrounding where the agency and its 890-member staff will call home next may linger for months, if not years.

August 01, 2016

A look at the EMA’s proposed guidance revisions for first-in-human studies.

August 01, 2016

Janssen releases key findings from its pilot study evaluating the use of electronic informed consent technology in clinical trials.

August 01, 2016

A patient-centric approach to a Phase IV trial for an MS treatment resulted in lessons that can be applied to future therapeutic studies for this and other rare diseases.

August 01, 2016

More precision models in connecting patients to clinical trials and treatment options are vying to close the ever-elusive recruitment gap.

August 01, 2016

Survey delves deep into what constitutes true game-changing innovation in clinical development.

August 01, 2016

The need to move beyond a point-solutions approach to one built around applications designed to manage the end-to-end clinical trial process is crucial.

August 01, 2016

A proposed operational framework to support digital- and mHealth-based clinical trials in Africa.

August 01, 2016

Exploring the benefits from cross-company data sharing for study planning and investigator selection.

August 01, 2016

An examination of recent failures in Phase III studies and innovative approaches to reduce risk.

August 01, 2016

Research reveals a need for sponsors to be much more consistent, disciplined and focused in their CRO usage.

August 01, 2016

Study measures the differing judgment levels between clinical investigators and drug safety experts.

August 01, 2016

Click the title above to open the Applied Clinical Trials August/September 2016 issue in an interactive PDF format.